ストックスクリーナーアプリを入手
0.00
100.00%
-63.48
アフターアワーズ：
63.50
63.50
+
前日終値:
$63.48
開ける：
$0
24時間の取引高:
0
Relative Volume:
0.00
時価総額：
$11.52B
収益：
$4.42B
当期純損益:
$-413.00M
株価収益率:
0.00
EPS:
-2.27
ネットキャッシュフロー:
$99.00M
1週間 パフォーマンス:
-100.00%
1か月 パフォーマンス:
-100.00%
6か月 パフォーマンス:
-100.00%
1年 パフォーマンス:
-100.00%
1日の値動き範囲:
$0.00
$0.00
1週間の範囲:
$0.00
$0.00
52週間の値動き範囲:
$0.00
$63.50
Catalent Inc Stock (CTLT) Company Profile
CTLT を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CTLT
Catalent Inc
|
0.00 | 11.52B | 4.42B | -413.00M | 99.00M | -2.27 |
|
ZTS
Zoetis Inc
|
167.53 | 75.58B | 9.15B | 2.43B | 2.31B | 5.32 |
|
HLN
Haleon Plc Adr
|
9.24 | 41.78B | 14.26B | 1.55B | 0 | 0.3383 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.10 | 41.53B | 30.27B | 1.93B | 3.45B | 0.6044 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
21.82 | 24.72B | 16.77B | -959.00M | 1.37B | -0.85 |
|
NBIX
Neurocrine Biosciences Inc
|
145.88 | 14.77B | 2.24B | 385.90M | 440.10M | 3.73 |
Catalent Inc Stock (CTLT) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2023-11-16 | アップグレード | Robert W. Baird | Neutral → Outperform |
| 2023-09-05 | アップグレード | Argus | Hold → Buy |
| 2023-07-20 | 開始されました | Wells Fargo | Equal Weight |
| 2023-07-05 | 再開されました | JP Morgan | Neutral |
| 2023-06-14 | ダウングレード | Jefferies | Buy → Hold |
| 2023-05-22 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2023-05-15 | ダウングレード | Deutsche Bank | Buy → Hold |
| 2023-05-08 | ダウングレード | BofA Securities | Neutral → Underperform |
| 2023-04-17 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2023-04-14 | ダウングレード | William Blair | Outperform → Mkt Perform |
| 2023-04-10 | アップグレード | Deutsche Bank | Hold → Buy |
| 2023-04-03 | ダウングレード | Barclays | Overweight → Equal Weight |
| 2022-12-19 | ダウングレード | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2022-11-07 | ダウングレード | Argus | Buy → Hold |
| 2022-11-02 | ダウングレード | BofA Securities | Buy → Neutral |
| 2021-12-16 | 開始されました | Barclays | Overweight |
| 2020-12-10 | アップグレード | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2020-06-25 | 開始されました | Argus | Buy |
| 2020-04-21 | 開始されました | RBC Capital Mkts | Outperform |
| 2020-03-02 | 開始されました | Deutsche Bank | Hold |
| 2019-10-17 | 再開されました | Stephens | Overweight |
| 2019-08-28 | ダウングレード | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2019-06-21 | アップグレード | Jefferies | Hold → Buy |
| 2019-04-16 | アップグレード | UBS | Neutral → Buy |
| 2018-11-07 | アップグレード | First Analysis Sec | Neutral → Outperform |
| 2018-10-09 | 開始されました | UBS | Neutral |
| 2018-03-28 | アップグレード | KeyBanc Capital Mkts | Sector Weight → Overweight |
| 2018-03-21 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2018-02-06 | ダウングレード | Stephens | Overweight → Equal-Weight |
| 2017-09-21 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2017-09-13 | 開始されました | Needham | Hold |
| 2017-09-08 | ダウングレード | KeyBanc Capital Mkts | Overweight → Sector Weight |
| 2016-12-01 | 開始されました | Goldman | Neutral |
| 2016-10-20 | 開始されました | KeyBanc Capital Mkts | Overweight |
| 2016-06-21 | アップグレード | Wells Fargo | Market Perform → Outperform |
| 2016-06-20 | アップグレード | BofA/Merrill | Neutral → Buy |
すべてを表示
Catalent Inc (CTLT) 最新ニュース
Catalent to Support Galapagos’ Decentralized CAR-T Therapy Trials - Contract Pharma
Catalent, Inc. (NYSE:CTLT) Given Average Rating of “Hold” by Analysts - Defense World
StockNews.com Begins Coverage on Catalent (NYSE:CTLT) - Defense World
Novo Holdings looks to double Catalent size with eye on Trump US manufacturing focus - Yahoo Finance
JPM 2025: Thermo Fisher ‘very positive’ on sterile demand as Catalent takes capacity out of market - Pharmaceutical Technology
Catalent (NYSE:CTLT) Now Covered by Analysts at StockNews.com - Defense World
Novo Holdings completes purchase of Catalent - MSN
Catalent (NYSE:CTLT) Coverage Initiated by Analysts at StockNews.com - Defense World
JPMorgan Chase & Co. Acquires 199,427 Shares of Catalent, Inc. (NYSE:CTLT) - Defense World
Sarepta's Expanded Approval Unlikely To Influence Novo Holdings' Acquisition of Catalent, But Provides Investor Protection Amid Uncertainty - MSN
Trump Nominates Olivia Trusty for FCC Commissioner Role Ahead of Inauguration - PYMNTS.com
Principal Financial Group Inc. Has $12.61 Million Position in Catalent, Inc. (NYSE:CTLT) - Defense World
Catalent, Inc. (NYSE:CTLT) Receives Consensus Rating of “Hold” from Brokerages - Defense World
MML Investors Services LLC Has $442,000 Stake in Catalent, Inc. (NYSE:CTLT) - Defense World
Staff AccountantCatalent, Inc. - Built In
Novo Nordisk Set to Close Catalent Deal Without FTC Challenge - MSN
Novo Holdings completes $16.5 billion takeover of Catalent - MSN
Novo Holdings says its acquisition of Catalent is complete. - The Herald-Times
Novo Holdings Strengthens Pharma Standing With Catalent Acquisition - Finimize
Catalent, Inc Announces Board Changes - Marketscreener.com
Regulatory conditions on Novo Holdings' $16.5 billion Catalent deal fulfilled, companies say - MSN
Novo Holdings closes $16.5 billion buyout of contract manufacturer Catalent - MSN
Novo Holdings completes Catalent acquisition for $16.5bn - Yahoo Finance
Lennox To Join S&P 500 Index, Replacing Catalent - Yahoo! Voices
This industrials company is joining the S&P 500 soon - MSN
Novo Holdings completes $16.5B acquisition of Catalent - Inside INdiana Business
Novo Completes $16.5 Billion Acquisition of Catalent - Yahoo Finance
Novo Holdings Completes Acquisition of Catalent - citybiz
Catalent Acquired by Novo Holdings in $16.5 Billion Deal - TipRanks
Novo Holdings Finalizes $16.5 Billion Acquisition of CatalentNews and Statistics - IndexBox, Inc.
Catalent : Novo Holdings Completes Acquisition of Catalent Form 8 K - Marketscreener.com
Catalent acquired by Novo Holdings for $16.5 billion - Investing.com
Novo Holdings has completed the acquisition of Catalent - Marketscreener.com
The acquisition of Catalent by Novo Holdings, and the - GlobeNewswire
The acquisition of Catalent by Novo Holdings, and the related acquisition by Novo Nordisk of three manufacturing sites from Novo Holdings, is completed - Yahoo Finance UK
Novo Holdings Completes Massive $16.5B Catalent Acquisition, Offering 47.5% Premium to Shareholders - StockTitan
Novo Nordisk Invests $1.2 Billion in New Denmark Factory, Fresh Off Catalent Deal - geneonline
Catalent wins EU approval for planned $16.5B sale to Novo Holdings - MSN
Novo Nordisk’s New Deal May End Wegovy Shortages. It Could Reshape Pharma Industry Along the Way. - Barron's
Danish pharma giant cleared to buy Catalent - Indiana Public Media
House Panel Accuses Financial Firms of Collusion Over ESG Goals - PYMNTS.com
Novo Holdings Completes Regulatory Hurdles For Catalent Acquisition - Contract Pharma
Novo Holdings’ $16.5B deal for Catalent clears last regulatory hurdle - MM+M Online
Catalent Inc (CTLT) 財務データ
収益
当期純利益
現金流量
EPS
0.24%
大文字化:
|
ボリューム (24 時間):